首页> 外文期刊>EFSA Journal >Scientific Opinion on the substantiation of health claims related to docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA) and gamma‐linolenic acid (GLA) and contribution to normal cognitive function (ID 532) and maintenance of normal bone (ID 642, 697, 1552) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
【24h】

Scientific Opinion on the substantiation of health claims related to docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA) and gamma‐linolenic acid (GLA) and contribution to normal cognitive function (ID 532) and maintenance of normal bone (ID 642, 697, 1552) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

机译:关于证实与二十二碳六烯酸(DHA),二十碳五烯酸(EPA)和γ-亚麻酸(GLA)有关的健康主张以及对正常认知功能的贡献(ID 532)和维持正常骨骼(ID 642、697, 1552)符合1924/2006号法规(EC)第13(1)条

获取原文
       

摘要

This opinion addresses the scientific substantiation of health claims in relation to docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA) and gamma-linolenic acid (GLA) and contribution to normal cognitive function and maintenance of normal bone. The scientific substantiation is based on the information provided by the Member States in the consolidated list of Article 13 health claims and references that EFSA has received from Member States or directly from stakeholders. The food constituents that are the subjects of the health claims are “omega-3 and omega-6 fatty acids (GLA)”, “gamma-linolenic acid + eicosapentaenoic acid (GLA+EPA)”, and “evening primrose oil and fish oil”. From the references provided, the Panel assumes that the food constituents that are the subject of the claims are the n-6 fatty acid gamma-linolenic acid (GLA) in evening primrose oil and the n-3 long-chain polyunsaturated fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) in fish oil. The Panel considers that the food constituents, DHA, EPA and GLA, are sufficiently characterised. Contribution to normal cognitive function The claimed effect is “brain function (adult & children)”. The Panel assumes that the target population is the general population. In the context of the clarifications provided by Member States, 1 On request from the European Commission, Question No EFSA-Q-2008-1319, EFSA-Q-2008-1429, EFSA-Q-2008-1484, EFSA-Q-2008-2289, adopted on 25 March 2011. Panel members: Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Hannu Korhonen, Pagona Lagiou, Martinus L?vik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuh?user-Berthold, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, Hendrik van Loveren and Hans Verhagen.
机译:该意见涉及与二十二碳六烯酸(DHA),二十碳五烯酸(EPA)和γ-亚麻酸(GLA)有关的健康主张的科学依据,以及对正常认知功能和正常骨骼维护的贡献。科学依据是成员国在第13条健康声明综合清单中提供的信息,以及EFSA从成员国或直接从利益相关者那里获得的参考。属于健康声明主题的食物成分是“ omega-3和omega-6脂肪酸(GLA)”,“γ-亚麻酸+二十碳五烯酸(GLA + EPA)”和“月见草油和鱼油” ”。根据提供的参考资料,小组认为,作为权利要求主题的食物成分是月见草油中的n-6脂肪酸γ-亚麻酸和n-3长链多不饱和脂肪酸二十二碳六烯酸鱼油中的DHA和二十碳五烯酸(EPA)。小组认为,食品成分DHA,EPA和GLA具有足够的特征。对正常认知功能的贡献声称的作用是“脑功能(成人和儿童)”。小组认为目标人口是普通人口。根据成员国的说明,1根据欧洲委员会的要求,问题编号EFSA-Q-2008-1319,EFSA-Q-2008-1429,EFSA-Q-2008-1484,EFSA-Q-2008 -2289,于2011年3月25日获得通过。小组成员:卡洛·阿戈斯托尼,让·路易·布雷森,苏珊·费尔威瑟·泰特,阿尔伯特·弗林,伊内斯·戈利,汉努·科洪宁,帕格纳·拉乔,马丁努斯·维克,罗珊格拉·马尔凯利,安布罗斯·马丁,贝文·莫斯利,Monika Neuh?user-Berthold,Hildegard Przyrembel,Seppo Salminen,Yolanda Sanz,Sean(JJ)Strain,Stephan Strobel,Inge Tetens,DanielTomé,Hendrik van Loveren和Hans Verhagen。

著录项

  • 来源
    《EFSA Journal》 |2011年第6期|共16页
  • 作者

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种
  • 中图分类 食品工业;
  • 关键词

  • 入库时间 2022-08-18 10:03:54

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号